You are here: Industry Insights > CoronaVac

News List

Elderly Chileans line up for booster jabs to reinforce CoronaVac vaccine firstwordpharma
August 12, 2021
Chile on Wednesday began administering booster shots to people already vaccinated with Sinovac’s COVID-19 vaccine, as reported by the National Post.
Chilean Sinovac trial leaders recommend third dose of COVID-19 vaccine firstwordpharma
July 16, 2021
The leaders of Chile’s late-stage human trial of Sinovac’s COVID-19 vaccine CoronaVac recommended a third dose of the shot, saying studies of participants showed their protecting antibody levels were lower after six months, as reported by Yahoo!News
Sinovac Biotech signs up to supply COVAX with CoronaVac cphi-online
July 15, 2021
China-based company could supply up to 380 million doses from July 2021 through to June 2022
Sinopharm and Sinovac to deliver 550 million vaccine doses to Gavi pharmaceutical-technology
July 14, 2021
Gavi, the Vaccine Alliance has signed advance purchase agreements (APAs) for a total of up to 550 million doses of Covid-19 vaccines from Sinopharm and Sinovac for supply through the COVAX facility.
SINOVAC signs agreement to supply CoronaVac to COVAX expresspharma
July 13, 2021
SINOVAC Biotech announced that it has signed an advance purchase agreement (APA) with Gavi, the Vaccine Alliance, which is on behalf of COVAX Facility, to provide up to 380 million doses of inactivated COVID-19 vaccine, CoronaVac for distribution ...
SAHPRA Authorises the CoronaVac Vaccine with Conditions firstwordpharma
July 05, 2021
The South African Health Products Regulatory Authority (SAHPRA) has authorised the CoronaVac COVID-19 vaccine, manufactured by Sinovac Life Sciences Co, and imported by Curanto Pharma (Pty) Ltd.
Sinovac COVID-19 vaccine gets WHO validation for emergency use expresspharma
June 02, 2021
WHO’s Emergency Use Listing (EUL) is a prerequisite for COVAX Facility vaccine supply and international procurement.
Sinovac Biotech vaccine effective in controlling Covid-19, new study shows firstwordpharma
June 01, 2021
Preliminary numbers show that Sinovac’s vaccine was effective in controlling COVID-19 in a mass-inoculation study in a small Brazilian town after 75% of adults were covered with a second shot, as reported by The Irish Times.
Sinovac’s Covid-19 vaccine prevents 67% symptomatic infections in study pharmaceutical-technology
April 20, 2021
The Chilean Ministry of Health has reported that the Chinese pharmaceutical company Sinovac Covid-19 vaccine CoronaVac demonstrated to be up to 67% effective in preventing symptomatic infections in a study.
Sinovac’s Covid-19 vaccine trial triggers immune responses in children pharmaceutical-technology
March 24, 2021
China-based company Sinovac Biotech has reported that preliminary results from Phase I and II clinical trials of its Covid-19 vaccine, CoronaVac, demonstrated it to be safe and could induce immune responses among children and adolescents.

Previous page 1 2 3 Next page